The Series Dedicated to the 14th International Thymic Malignancy Interest Group Annual Meeting (ITMIG 2024) was edited by Dr. Malgorzata Szolkowska (The National Tuberculosis and Lung Diseases Research Institute, Poland).
Review Article
Pathogenesis of thymoma-associated myasthenia gravis: a narrative review
Factors distinguishing thymomas from thymic squamous cell carcinoma: a proposal for diagnosis emphasizing the immunophenotype
Phrenic nerve reconstruction after combined resection in malignant tumors: a narrative review
Thymic hyperplasia in myasthenia gravis: a narrative review
Mediastinal tumors: why, when, and how to biopsy?
Narrative review: this or that?—uncommon challenges in mediastinal pathology
When rarity meets thoracic cancers: a narrative review from ITMIG 2024
Surveillance of thymic epithelial tumors (TETs)—a narrative review
Hyperthermic intrathoracic chemotherapy (HITHOC) in stage IVA thymomas: a narrative review
Narrative review of the prognostic significance of primary tumor size in thymic epithelial tumor
Artificial intelligence for diagnosis and prognosis of thymic epithelial tumors: a systematic review
Case Report
Complete pathologic response after concomitant pembrolizumab and radiotherapy in a patient with pretreated metastatic thymic carcinoma: a case report
Disclosure:
The Series Dedicated to the 14th International Thymic Malignancy Interest Group Annual Meeting (ITMIG 2024) was commissioned by the editorial office, Mediastinum without any sponsorship or funding. Dr. Malgorzata Szolkowska served as the unpaid Guest Editor for the series.